Galectin Therapeutics Inc. PHPN.F Stock
Galectin Therapeutics Inc. Price Chart
Galectin Therapeutics Inc. PHPN.F Financial and Trading Overview
| Galectin Therapeutics Inc. stock price | 2.9 EUR |
| Previous Close | 1.28 EUR |
| Open | 1.31 EUR |
| Bid | 1.31 EUR x 227700 |
| Ask | 1.36 EUR x 219000 |
| Day's Range | 1.31 - 1.31 EUR |
| 52 Week Range | 0.95 - 2.4 EUR |
| Volume | 400 EUR |
| Avg. Volume | 0 EUR |
| Market Cap | 79.47M EUR |
| Beta (5Y Monthly) | 1.399647 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.68 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 14 EUR |
PHPN.F Valuation Measures
| Enterprise Value | 114.46M EUR |
| Trailing P/E | N/A |
| Forward P/E | -1.8714285 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Galectin Therapeutics Inc. Stock Price History
| Beta (5Y Monthly) | 1.399647 |
| 52-Week Change | 10.00% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 2.4 EUR |
| 52 Week Low | 0.95 EUR |
| 50-Day Moving Average | 1.6 EUR |
| 200-Day Moving Average | 1.47 EUR |
PHPN.F Share Statistics
| Avg. Volume (3 month) | 0 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | 59.58M |
| Float | 42.29M |
| Short Ratio | N/A |
| % Held by Insiders | 29.03% |
| % Held by Institutions | 12.07% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:6 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -89.98% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | -40484000 EUR |
| Diluted EPS (ttm) | -0.59 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 17.8M EUR |
| Total Cash Per Share (mrq) | 0.3 EUR |
| Total Debt (mrq) | 51.38M EUR |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 1.695 |
| Book Value Per Share (mrq) | -0.753 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -33807000 EUR |
| Levered Free Cash Flow (ttm) | -20172624 EUR |
Profile of Galectin Therapeutics Inc.
| Country | Germany |
| State | GA |
| City | Norcross |
| Address | 4960 Peachtree Industrial Boulevard |
| ZIP | 30071 |
| Phone | 678 620 3186 |
| Website | https://galectintherapeutics.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 12 |
Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of therapies for fibrotic, cancer, and other diseases. Its lead product candidate is belapectin (GR-MD-02) galectin-3 inhibitor, a galactoarabino-rhamnogalacturonan polysaccharide polymer that is in Phase III clinical trial for the treatment of liver fibrosis associated with fatty liver disease and non-alcoholic steatohepatitis cirrhosis, as well as for the treatment of cancer. The company, through its Galectin Sciences, LLC, which is a collaborative joint venture co-owned by SBH Sciences, Inc., to research and development of small organic molecule inhibitors of galectin-3 for oral administration. The company was formerly known as Pro-Pharmaceuticals, Inc. and changed its name to Galectin Therapeutics, Inc. in May 2011. Galectin Therapeutics Inc. was founded in 2000 and is based in Norcross, Georgia.
Q&A For Galectin Therapeutics Inc. Stock
What is a current PHPN.F stock price?
Galectin Therapeutics Inc. PHPN.F stock price today per share is 2.9 EUR.
How to purchase Galectin Therapeutics Inc. stock?
You can buy PHPN.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Galectin Therapeutics Inc.?
The stock symbol or ticker of Galectin Therapeutics Inc. is PHPN.F.
Which industry does the Galectin Therapeutics Inc. company belong to?
The Galectin Therapeutics Inc. industry is Biotechnology.
How many shares does Galectin Therapeutics Inc. have in circulation?
The max supply of Galectin Therapeutics Inc. shares is 62.15M.
What is Galectin Therapeutics Inc. Price to Earnings Ratio (PE Ratio)?
Galectin Therapeutics Inc. PE Ratio is now.
What was Galectin Therapeutics Inc. earnings per share over the trailing 12 months (TTM)?
Galectin Therapeutics Inc. EPS is -0.68 EUR over the trailing 12 months.
Which sector does the Galectin Therapeutics Inc. company belong to?
The Galectin Therapeutics Inc. sector is Healthcare.